Skip to main content

Houston Health Care Innovation Takes Spotlight at Global Summit

Published Aug 12, 2021 by Maggie Martin

Robert Pieroni

Robert Pieroni, Economic Development Director at Central Houston, participated in a virtual panel discussion about innovation on August 11

Josh Sol

Josh Sol, Administrative Director of Innovation and Ambulatory Clinical Systems at Houston Methodist Hospital, was a panelist as part of the HealthTech Beyond Borders virtual event

Leaders from Houston's innovation ecosystem recently told an international audience how the nation's fourth largest city is supporting new technologies, products and services within one of the most robust health care systems in the world. 

Josh Sol, Administrative Director of Innovation and Ambulatory Clinical Systems at Houston Methodist, and Robert Pieroni, Economic Development Director at Central Houston, took part in a panel highlighting health care innovation on August 11. The discussion was part of HealthTech Beyond Borders, a virtual global conference created to help facilitate business opportunities for medical technology companies in the U.S. and Chile. The event also included speakers from innovation hubs in Chicago and Philadelphia.

Here are highlights of what Sol and Pieroni said during the discussion:

On why international health care startups prioritize the Houston market

“There is a tone and shift that we’re seeing in the Houston area that is focusing in on innovation,” said Sol, who noted Houston Methodist's hub alone has drawn interest from innovators all over the world. Methodist is one of 61 member institutions that make up the Texas Medical Center, the largest medical complex in the world. 

Pieroni underscored TMC's world-renowned reputation in health care.

"When you really start looking at it from a scale perspective of patient testing and data, we really dwarf just about every other city around the world, and so it’s something we’re very proud of,” said Pieroni. “It is one of our unique assets that we’re actually building upon to be the Third Coast for Life Sciences.”

On how Houston supports health care startups

"2017 was our awakening to jumpstart the Houston innovation economy," said Pieroni, alluding to how Houston's unsuccessful bid for Amazon's second headquarters, HQ2, was a turning point for the city's innovation ecosystem. "Along that line, we started to create hubs for startups to land with coworking, accelerators, incubators, and really all those wraparound services."

Pieroni pointed to a few of those hubs, including Downtown Launchpad, a 17,000-square-foot innovation hub in the Amegy Bank Houston building on Main with resident partners including startup accelerators MassChallenge and gener8tor, as well as incubator Impact Hub Houston. He also talked about The Ion, the 266,000-square foot hub in the renovated Sears building at the heart of the Innovation District  designed to bring entrepreneurs, corporate and academic communities together in a collaborative space. He also mentioned health care innovation specifically a focus at places like JLABS @ TMC, the startup accelerator and biotech incubator that serves as the largest JLABS footprint in the U.S. with over 34,000 square feet of common, wet lab and office space.

Sol acknowledged the health care industry can be challenging for startups to break into, but added founders can find a welcoming environment in Houston. 

"Getting into a health care organization is definitely hard, especially to start doing pitches," he said. "I would say there is a flavor and a change that’s happening in the [Texas Medical Center] where it’s a little bit easier to get your companies in to pitch to an innovation team.” 

Sol also touched on the impact COVID-19 has had on the health care industry. 

“Health care is in a digital evolution," he said. "While the pandemic has been tremendously impactful, we’ve seen health care digital adoption increase by 10 years in the span of one because of the pandemic.”

On what early-stage companies need to consider and what steps they need to take to best prepare themselves to receive funding

Pieroni laid out what startups should consider as they pursue funding, including:

  •  Are you VC-backable? "Most startups – it is a term that is so vague now – but most startups think they’re venture-backable. They’re not," he said. "So, it’s really looking at your scale, your opportunity to scale. And then, of course, is it labor intensive? Some of the things you need to think about as you dive into that market.”
     
  • Where are you in the life cycle of getting funding? "Many people think they’re ready for funding when they’re actually not," said Pieroni. "That is one thing that getting into an accelerator - and this kind of goes to the point of deal flow - when you get accepted into an accelerator, it’s an elite group of startups that you’re being accepted into.” He added MassChallenge and gener8tor as examples of these competitive programs, where only 8-11% of startups are accepted. However, applying for accelerator programs is worth the effort, as Pieroni noted that being accepted means the startup has been heavily vetted, which is attractive to potential investors.
     
  • VC is no longer geographically-bound. "It doesn’t matter where you are in the United States. If you have a good product and a good company, you will be funded."
     
  • Do your due diligence on the VC firms you want to target. "A lot of startups throw their decks at venture funds that have no interest in what they do," said Pieroni. He urged startups to research a VC firm's portfolio companies and ensure you wouldn't be a direct competitor, since you'll be sharing valuable information about your startup in your deck.

Pieroni and Sol both encouraged founders to get connected and involved with Houston's innovation ecosystem.

On VC investment growth in Houston

Houston has already raised $1 billion in venture capital in the first half of 2021. Life sciences and health care have become Houston's top-funded VC-funded industry, ahead of information technology and energy.

"So we have just seen a flood of venture capital money, and I think it’s because we have built these hubs that allow people to go to places to see large concentrations of startups," said Pieroni.
 

Learn more about Houston's health care and life sciences ecosystems. Read about innovation in Houston. Watch a Small Biz Insider interview with Robert Pieroni about Downtown Launchpad.

Related News

Health Care

University of Houston, Baylor College of Medicine to Launch Cutting-Edge Research Hub

8/26/24
The University of Houston (UH) and Baylor College of Medicine (BCM) have been awarded a $44.2 million grant from the National Center for Advancing Translational Research. This funding will support the establishment of a regional hub dedicated to advancing clinical and translational research.  Dubbed the Consortium for Translational and Precision Health (CTPH), the new hub will enhance collaboration between the two institutions and other clinical and research groups within the Texas Medical Center. The CTPH aims to expedite the translation of new technologies and discoveries into patient care and real-world impact, provide funding and resources to accelerate pilot projects and research initiatives and connect investigators with local healthcare organizations and government agencies that are dedicated to healthcare, clinical research and policy.  “Research is the engine empowering health care’s life-changing advancements,” said UH President Renu Khator, in a release. “This innovative hub will be a catalyst for groundbreaking discoveries and treatments that improve people’s quality of life. That’s what drives us at UH and we’re ecstatic to cofound a regional hub for change alongside Baylor.”  The hub will be led by BCM’s Christopher Amos, professor and director of the Institute for Clinical and Translational Research, and Dr. Fasiha Kanwal, professor of medicine and chief of the section of gastroenterology and hepatology, alongside UH’s Dr. Bettina M. Beech, clinical professor of population health and chief population health officer.  “The CTPH is a partnership that draws on strengths of both institutions, creating a rich multidisciplinary environment. It will act as the vehicle to enhance the infrastructure and resources needed to effectively conduct research and implement solutions to advance healthcare,” said Dr. Carolyn Smith, interim senior vice president and dean of research at BCM. “It will help implement and create ongoing core research activities that will support the clinical translational science at both institutions.”  This strategic partnership comes at a time when local institutions are intensifying efforts to advance critical research that will deliver vital healthcare solutions. The University of Texas MD Anderson Cancer Center and Rice University recently announced a collaboration to advance fundamental and translational cancer research and develop life-saving technologies. Additionally, a research initiative led by Rice University, in collaboration with MD Anderson, received an $18 million grant to improve tumor removal technology for breast, head and neck cancer.  Learn more about Houston’s Life Sciences industry. 
Read More
Economic Development

Houston's Life Sciences Sector on the Verge of a New Era

2/27/24
Houston continues to evolve as a premier destination for life sciences and biomanufacturing through a multifaceted strategy that capitalizes on its existing strengths and fosters innovation and growth.   Since its inception in 1945, the Texas Medical Center has evolved into a vast medical district spanning 5 square miles  and serving over ten million patients annually.  More than 60 institutions operate within the Texas Medical Center, serving as a catalyst for Houston’s collaborative ecosystem, with efforts like the Cell Therapy Manufacturing Center, JLABS@TMC and CUBIO. This helps set the stage for groundbreaking research and provides direct access to nearly 5,000 active clinical trials, a major boon to innovation.   Recent years have witnessed significant strides in laying a robust foundation for Houston's position as a leader in innovative life sciences and biotechnology. These efforts came into focus last month at Bisnow’s Life Sciences Evolution event, with leaders in the life sciences industry, real estate and innovation envisioning the future growth of the Houston life sciences market. Among the assets shared as advantages were access to clinical trials, business environment, workforce efforts and quality of life.   “Having access to the patient population is critical to success, especially a diverse population,” Monique Knighten, PhD of Portal Innovations said. “There’s a key benefit to have access to these clinical trials and the expertise involved, as well as living close to where the science is being developed.”   Legislative actions, such as the passage of Proposition 10 in November which provides new incentives for medical device and pharmaceutical manufacturing companies, enhances the region's competitiveness and economic prospects. Additionally, investments in workforce development, exemplified by collaborations between educational institutions and industry partners like San Jacinto College and the National Institute for Bioprocessing Research and Training (NIBRT), ensure a skilled talent pool for the future.  “The relationships with companies, colleges and high schools are integral,” Pearland EDC Vice President Brian Malone said on the panel at Bisnow discussing suburban life sciences growth. “We’ve really worked hard on that with a business retention plan to find out what type of training and what type of workers these companies need.”   Furthermore, substantial real estate investments further support life sciences research and development. TMC’s Helix Park opened in 2023 with the TMC Collaborative Building and industry research hub Dynamic One, with new tenant Houston Methodist leasing 75,800 square feet. Just north inside the Medical District, Hines’ Levit Green is now leasing nearly 300,000 square feet of purpose-built lab and office space as part of a future 53-acre district. On the northeast side of the metro, McCord’s master-planned Generation Park recently broke ground on a new Center for Biotechnology in partnership with San Jacinto College. In The Woodlands, Alexandria is developing 8800 Technology Forest Place into 325,000 square feet of Class A space.   Initiatives such as the Cancer Prevention Research Institute of Texas (CPRIT) and a thriving innovation ecosystem further reinforce the city's position at the forefront of bioscience breakthroughs and economic impact.  With strategic advantages like its top-ranked port, diverse population, and accessibility to global markets, Houston is poised to further elevate its status as a hub for life sciences innovation. As Houston continues to advance its life sciences and biotechnology sector, opportunities for collaboration and growth abound, driving progress in public health and driving the next wave of bioscience innovation.   Explore Houston's dynamic life sciences ecosystem.  
Read More

Related Events

Economic Development

Houston's Advancements in Biotechnology

Join us for an insightful panel on the life science and biotechnology industry, where experts will dive into the latest trends, innovations, and transformative developments shaping the field. Our panelists, each…

Learn More
Learn More
Executive Partners